Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart® Molecule for T-Cell Redirected Therapy

被引:9
|
作者
Jacobs, Kenneth [1 ]
Viero, Cedric [2 ]
Godwin, John [3 ]
Baughman, Jan [4 ]
Sun, Jichao [1 ]
Ying, Kang [1 ]
Muth, John [1 ]
Hong, Shengyan [1 ]
Vey, Norbert [5 ]
Sweet, Kendra L. [6 ]
Uy, Geoffrey L. [7 ]
Ravandi, Farhad [8 ]
Foster, Matthew C. [9 ]
Rizzieri, David A. [10 ]
Arellano, Martha L. [11 ]
Rettig, Michael P. [12 ]
Topp, Max S. [13 ]
Huls, Gerwin [14 ]
Lelievre, Helene [2 ]
Paolini, Stefania [15 ]
Ciceri, Fabio [16 ]
Carrabba, Matteo Giovanni [17 ]
Lowenberg, Bob [18 ]
DiPersio, John F. [12 ]
Wigginton, Jon [1 ]
Davidson-Moncada, Jan K. [19 ]
机构
[1] MacroGenics Inc, Rockville, MD USA
[2] Servier, Paris, France
[3] Providence Portland Med Ctr, Portland, OR USA
[4] MacroGenics Inc, San Francisco, CA USA
[5] Inst Paoli Calmettes, Dept Hematol, Marseille, France
[6] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL USA
[7] Washington Univ, Sch Med, St Louis, MO USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[9] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA
[10] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA
[11] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[12] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA
[13] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[14] Univ Med Ctr Groningen, Hematol, Groningen, Netherlands
[15] Univ Bologna, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy
[16] Ist Sci San Raffaele, Hematol & Bone Marrow Transplantat Unit, Milan, Italy
[17] IRCCS San Raffaele Sci Inst, Hematol & Bone Marrow Transplantat Unit, Milan, Italy
[18] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands
[19] MacroGenics Inc, Washington, DC USA
关键词
D O I
10.1182/blood-2018-99-112615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2738
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Risk and Severity of Cytokine Release Syndrome in Patients with Relapsed/Refractory (R/R) AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
    Lim, Tara L.
    Watts, Justn M.
    Mims, Alice S.
    Patel, Prapti
    Shami, Paul J.
    Cull, Elizabeth H.
    Cogle, Christopher R.
    Lee, Cynthia
    Uckun, Faith
    BLOOD, 2021, 138
  • [32] Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study
    Ravandi, Farhad
    Bashey, Asad
    Stock, Wendy
    Foran, James M.
    Mawad, Raya
    Egan, Daniel
    Blum, William
    Yang, Allen
    Pastore, Alessandro
    Johnson, Chelsea
    Zheng, Shuo
    Yilmaz, Musa
    Mims, Alice S.
    BLOOD, 2020, 136
  • [33] Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
    Lefevre, Apolline
    Parra-Guillen, Zinnia P.
    Troconiz, Inaki F.
    Boetsch, Christophe
    Frances, Nicolas
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [34] CD3 x CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation
    Willems, A
    Schoonooghe, S
    Eeckhout, D
    De Jaeger, G
    Grooten, J
    Mertens, N
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (11) : 1059 - 1071
  • [35] Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.
    Buelow, Ben
    Dang, Kevin
    Dalvi, Pranjali
    Li, Yuping
    Cheung, Alexander
    Rancan, Chiara
    Sankaran, Preethi
    Duy Pham
    Harris, Katherine
    Davison, Laura
    Balasubramani, Aarti
    Clarke, Starlynn
    Starzinski, Alec
    Fong, Lawrence
    Iyer, Suhasini
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] FDA approves first DLL3 x CD3 bispecific T-cell engager for lung cancer
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (07) : 487 - 487
  • [37] Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
    Haber, Lauric
    Olson, Kara
    Kelly, Marcus P.
    Crawford, Alison
    DiLillo, David J.
    Tavare, Richard
    Ullman, Erica
    Mao, Shu
    Canova, Lauren
    Sineshchekova, Olga
    Finney, Jennifer
    Pawashe, Arpita
    Patel, Supriya
    McKay, Ryan
    Rizvi, Sahar
    Damko, Ermelinda
    Chiu, Danica
    Vazzana, Kristin
    Ram, Priyanka
    Mohrs, Katja
    D'Orvilliers, Amanda
    Xiao, Jenny
    Makonnen, Sosina
    Hickey, Carlos
    Arnold, Cody
    Giurleo, Jason
    Chen, Ya Ping
    Thwaites, Courtney
    Dudgeon, Drew
    Bray, Kevin
    Rafique, Ashique
    Huang, Tammy
    Delfino, Frank
    Hermann, Aynur
    Kirshner, Jessica R.
    Retter, Marc W.
    Babb, Robert
    MacDonald, Douglas
    Chen, Gang
    Olson, William C.
    Thurston, Gavin
    Davis, Samuel
    Lin, John C.
    Smith, Eric
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
    Lauric Haber
    Kara Olson
    Marcus P. Kelly
    Alison Crawford
    David J. DiLillo
    Richard Tavaré
    Erica Ullman
    Shu Mao
    Lauren Canova
    Olga Sineshchekova
    Jennifer Finney
    Arpita Pawashe
    Supriya Patel
    Ryan McKay
    Sahar Rizvi
    Ermelinda Damko
    Danica Chiu
    Kristin Vazzana
    Priyanka Ram
    Katja Mohrs
    Amanda D’Orvilliers
    Jenny Xiao
    Sosina Makonnen
    Carlos Hickey
    Cody Arnold
    Jason Giurleo
    Ya Ping Chen
    Courtney Thwaites
    Drew Dudgeon
    Kevin Bray
    Ashique Rafique
    Tammy Huang
    Frank Delfino
    Aynur Hermann
    Jessica R. Kirshner
    Marc W. Retter
    Robert Babb
    Douglas MacDonald
    Gang Chen
    William C. Olson
    Gavin Thurston
    Samuel Davis
    John C. Lin
    Eric Smith
    Scientific Reports, 11
  • [39] THE ROLE OF T-CELL ACTIVATION IN ANTI-CD3 X ANTITUMOR BISPECIFIC ANTIBODY THERAPY
    WEINER, GJ
    KOSTELNY, SA
    HILLSTROM, JR
    COLE, MS
    LINK, BK
    WANG, SL
    TSO, JY
    JOURNAL OF IMMUNOLOGY, 1994, 152 (05): : 2385 - 2392
  • [40] Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123xCD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Vadakekolathu, Jayakumar
    Minden, Mark D.
    Hood, Tressa
    Church, Sarah E.
    Reeder, Stephen
    Altmann, Heidi
    Sullivan, Amy H.
    Viboch, Elena J.
    Patel, Tasleema
    Ibrahimova, Narmin
    Warren, Sarah E.
    Arruda, Andrea
    Schmitz, Marc
    Liang, Yan
    Cesano, Alessandra
    Pockley, A. Graham
    Valk, Peter
    Lowenberg, Bob
    Bornhauser, Martin
    Tasian, Sarah K.
    Rettig, Michael P.
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    Rutella, Sergio
    BLOOD, 2019, 134